Topic
drug-approval
9 stories related to this topic, newest first.
news.sky.comscience18 days ago
NHS to offer new ovarian cancer drug to hundreds of patients
The National Institute for Health and Care Excellence approved mirvetuximab soravtansine for certain platinum-resistant ovarian cancers. NHS England estimates 400 patients in England could receive the treatment each year.
newscientist.comscience21 days ago
Pancreatic Cancer Drug Shows Doubled Survival in Early Results
A medication called daraxonrasib produced more than double the survival time previously seen in pancreatic cancer patients. The drug also received FDA approval for an early access program and began shipping this week.
ER
foxbusiness.comworld23 days ago
FDA Rejects Experimental Melanoma Drug Twice Over Study Design
The Food and Drug Administration turned down an experimental melanoma treatment on two separate occasions after raising questions about how the supporting clinical study was structured. The agency cited concerns with the trial's design as the basis for both rejections.
thebalitimes.comworld37 days ago
FDA Rejects Replimune Melanoma Treatment RP1
The Food and Drug Administration declined to approve RP1, a genetically engineered treatment for melanoma developed by Replimune. One-third of participants in a 140-patient clinical trial saw their tumors shrink or disappear. The agency cited the lack of a control arm comparing t…
medpagetoday.comscience38 days ago
NHS Approves Durvalumab for Treatment of Resectable Stomach Cancer
The National Institute for Health and Care Excellence has approved the immunotherapy drug durvalumab, also known as Imfinzi and made by AstraZeneca, for use by the NHS in adults with stomach cancer that has not spread extensively and can be surgically removed. An estimated 1,500…
The Independentworld45 days ago
NHS England to Roll Out Givinostat for Eligible Duchenne Muscular Dystrophy Patients
Givinostat will become available to around 530 eligible patients in England with Duchenne muscular dystrophy following a commercial agreement between its manufacturer and NHS England. The National Institute for Health and Care Excellence confirmed the decision after the company r…
propublica.orgworld58 days ago
FDA Issues Priority Vouchers to Three Companies for Psychedelic Medication Reviews
The Food and Drug Administration announced on April 24, 2026, that it is issuing national priority vouchers to three companies to fast-track reviews of psychedelic medications. The companies are studying psilocybin for depression and methylone for PTSD. The move follows President…
AB
Substrate placeholder — needs reviewscience71 days ago
FDA Rejects Cancer Drug Candidate Lifileucel on Second Attempt After Prior Review
The U.S. Food and Drug Administration has rejected the cancer drug candidate lifileucel for the second time. The drug, developed by Iovance Biotherapeutics, targets advanced melanoma. This decision follows an earlier rejection in 2023 and involves issues with manufacturing and da…
ST
Substrate placeholder — needs reviewscience52 days ago
FDA Withdraws Approval for GSK's Leucovorin in Treating Cerebral Folate Deficiency
The U.S. Food and Drug Administration is withdrawing approval for GlaxoSmithKline's leucovorin as a treatment for cerebral folate deficiency, a rare brain disorder. GSK stated that the withdrawal was anticipated as part of the original approval plan. The disorder involves symptom…
ST